437 related articles for article (PubMed ID: 9894260)
1. [Diagnostic value of 10 systematized and ultrasound-guided transrectal prostatic biopsies].
Ravery V; Billebaud T; Toublanc M; Boccon-Gibod L; Hermieu JF; Moulinier F; Blanc E; Delmas V; Boccon-Gibod L
Prog Urol; 1998 Dec; 8(6):1012-7. PubMed ID: 9894260
[TBL] [Abstract][Full Text] [Related]
2. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.
Guichard G; Larré S; Gallina A; Lazar A; Faucon H; Chemama S; Allory Y; Patard JJ; Vordos D; Hoznek A; Yiou R; Salomon L; Abbou CC; de la Taille A
Eur Urol; 2007 Aug; 52(2):430-5. PubMed ID: 17412489
[TBL] [Abstract][Full Text] [Related]
3. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
Men S; Cakar B; Conkbayir I; Hekimoglu B
J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
[TBL] [Abstract][Full Text] [Related]
4. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
[TBL] [Abstract][Full Text] [Related]
5. The value of percent free prostate specific antigen, prostate specific antigen density of the whole prostate and of the transition zone in Turkish men.
Akduman B; Alkibay T; Tuncel A; Bozkirli I
Can J Urol; 2000 Oct; 7(5):1104-9. PubMed ID: 11114873
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.
Stewart CS; Leibovich BC; Weaver AL; Lieber MM
J Urol; 2001 Jul; 166(1):86-91; discussion 91-2. PubMed ID: 11435830
[TBL] [Abstract][Full Text] [Related]
7. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
Iwaki H; Kajita Y; Shimizu Y; Yamauchi T
Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
[TBL] [Abstract][Full Text] [Related]
8. Minimum prostate-specific antigen (PSA) level diagnostic of prostate cancer.
Yesner R; Kelly LJ; Chan YK
Conn Med; 1996 Jul; 60(7):399-404. PubMed ID: 8758658
[TBL] [Abstract][Full Text] [Related]
9. [Differential diagnostic value of prostate-specific antigen in prostatic hyperplasia].
Maksimov VA; Kamalov AA; Karpov VK; Riaboĭ AV; Prokhorov AV
Urologiia; 2001; (2):37-40. PubMed ID: 11490716
[TBL] [Abstract][Full Text] [Related]
10. Significance of lateral biopsy specimens during transrectal ultrasound-guided prostate biopsies in Japanese men.
Shigemura K; Arakawa S; Yamanaka K; Kataoka N; Yuien K; Fujisawa M
Int J Urol; 2007 Oct; 14(10):935-8. PubMed ID: 17880293
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic approach to prostate cancer using total prostate specific antigen-based parameters together.
Serdar MA; Oguz O; Olgun A; Seçkin B; Ilgan S; Hasimi A; Salih M; Peker F; Kutluay T
Ann Clin Lab Sci; 2002; 32(1):22-30. PubMed ID: 11848613
[TBL] [Abstract][Full Text] [Related]
12. Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?
Brausi M; Castagnetti G; Dotti A; De Luca G; Olmi R; Cesinaro AM
J Urol; 2004 Sep; 172(3):906-8; discussion 908-9. PubMed ID: 15310995
[TBL] [Abstract][Full Text] [Related]
13. The value of free and total prostate specific antigen in identifying patients for prostatic biopsy and its relationship to Gleason score and number of positive cores.
Bulbul MA; Khauli RB; Nasr R; Hemady K; Wazzan W
J Med Liban; 2000; 48(2):59-62. PubMed ID: 11028151
[TBL] [Abstract][Full Text] [Related]
14. Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?
Abdel-Khalek M; Sheir KZ; El-Baz M; Ibrahiem el-H
Scand J Urol Nephrol; 2005; 39(1):49-55. PubMed ID: 15764271
[TBL] [Abstract][Full Text] [Related]
15. PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases.
Aksoy Y; Oral A; Aksoy H; Demirel A; Akcay F
Ann Clin Lab Sci; 2003; 33(3):320-3. PubMed ID: 12956448
[TBL] [Abstract][Full Text] [Related]
16. Improved prostate cancer detection with anterior apical prostate biopsies.
Wright JL; Ellis WJ
Urol Oncol; 2006; 24(6):492-5. PubMed ID: 17138129
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection.
Naughton CK; Miller DC; Mager DE; Ornstein DK; Catalona WJ
J Urol; 2000 Aug; 164(2):388-92. PubMed ID: 10893592
[TBL] [Abstract][Full Text] [Related]
18. A long follow-up on prostate specific antigen density and prostate biopsy.
Netto Júnior NR; De Lima ML; Lavoura Júnior Nda S; Apuzzo F; De Lucena RG
Arch Esp Urol; 1998 Dec; 51(10):1050-3. PubMed ID: 9951132
[TBL] [Abstract][Full Text] [Related]
19. [Cost analysis of ultrasound-guided transrectal needle biopsy in prostatic carcinoma].
Bissoli E; Fandella A; La Torre E; Faggiano L; Anselmo G; Frasson F
Radiol Med; 1998 Apr; 95(4):353-6. PubMed ID: 9676215
[TBL] [Abstract][Full Text] [Related]
20. Individualized prostate biopsy strategy for Chinese patients with different prostate-specific antigen levels.
Dai B; Ye DW; Kong YY; Shen YJ; Wang BH
Asian J Androl; 2008 Mar; 10(2):325-31. PubMed ID: 18097514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]